ArticleOncoimmunology2015

The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms.

Simona Porcellini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.